The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global e-prescribing market exhibited strong growth during 2015-2020. E-prescribing, or electronic prescribing, refers to a web or cloud-based solution that enables healthcare providers to generate digital prescriptions. It is a computer-based process for generating and transmitting accurate prescription orders to a hospital-based or standalone pharmacy. E-prescription software can automatically refill prescriptions for patients and manage medications according to their history and integrate them with an electronic medical record (EMR) system. In comparison to the traditionally used manual prescriptions, it offers various benefits, such as improved patient safety and healthcare quality, minimal risks of medication errors and loss of handwritten prescriptions and enhanced convenience for doctors and physicians.
Rapid digitization in the healthcare industry and the widespread adoption of electronic health records (EHRs), represent as the key factors driving the growth of the market. As the coronavirus disease (COVID-19) pandemic continues to spread across the globe, there has been a significant increase in the demand for telemedicine and telehealth solutions for providing specialized care to patients. Furthermore, the increasing focus of authorities on minimizing the abuse of controlled substances and the unauthorized distribution of pharmaceutical drugs is stimulating the market growth. E-prescription software can aid in identifying duplicate or fraudulent entries in prescriptions, thereby limiting pharmaceutical malpractices. Additionally, various technological advancements, such as the development of solutions with higher performance capabilities and ease of deployment, are acting as other growth-inducing factors. These systems improve organizational workflow and enhance patient compliance by providing cost-effective generic formulations. Other factors, including the implementation of favorable government policies to improve public health and extensive improvements in the healthcare infrastructure, are anticipated to drive the market further. Looking forward, IMARC Group expects the global e-prescribing market to grow at a CAGR of around 26% during the forecast period (2021-2026).
IMARC Group provides an analysis of the key trends in each sub-segment of the global e-prescribing market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, component, delivery mode, end user and specialties.
Breakup by Component:
Breakup by Delivery Mode:
Breakup by End User:
Breakup by Specialties:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Allscripts Healthcare Solutions Inc., Athenahealth Inc. (Veritas Capital and Evergreen Coast Capital), Cerner Corporation, Computer Programs and Systems Inc., DrFirst.com Inc., Epic Systems Corporation, Henry Schein Inc., Medical Information Technology Inc., Nextgen Healthcare Inc. and Surescripts LLC.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at